Jaden Bendabenda
Biographic Data
| ID | 5470981 |
|---|---|
| NAME | Jaden Bendabenda |
| GIVEN NAMES | Jaden |
| FAMILY NAME | Bendabenda |
| SIGNATURE | BENDABENDA J |
| AFFILIATIONS | World Health Organization |
| ORCID | 0000-0001-6231-1224 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 20 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Developing the 2023 WHO guideline on wasting and nutritional oedema in infants and children
The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years has a broad scope aligned with WHO’s responsibility to develop a comprehensive guideline as part of the Global Action Plan on Child Wasting. A WHO technical team consisting of the WHO Steering Committee for this guideline, supported by a consultant and two independent methodologists, coordinated guid…
A WHO global research priority agenda for wasting and nutritional oedema in infants and children under 5 years
INTRODUCTION: The guideline development process for the WHO guideline on prevention and management of wasting and nutritional oedema highlighted extensive evidence gaps. We, the WHO Steering Committee and methodologists for the 2023 WHO guideline, therefore aimed to develop a comprehensive global research priority agenda for wasting and nutritional oedema in infants and children. It has a timeframe up to 2030 aligning with the Sustainable Develop…
Strengthening the evidence base around prevention and management of wasting and nutritional oedema in infants and children
box In 2023, WHO released a guideline on prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years as part of the Global Action Plan on Child Wasting, a consolidated framework to accelerate progress in prevention and management of wasting and nutritional oedema
Development of core outcome sets for effectiveness trials focused on infants and children with wasting and nutritional oedema
INTRODUCTION: The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema includes recommendations informed by best evidence from systematic reviews addressing critical and important outcomes. Multiple outcomes across trials were a challenge during guideline development, highlighting a need to establish core outcome sets (COS) for wasting and nutritional oedema. Informed by Core Outcome Measures in Effectiveness Tria…
Infants and children 6–59 months of age with moderate wasting
BOX The 2023 WHO guideline on wasting and nutritional oedema provides the first systematically developed evidence-informed set of recommendations and good practice statements for children 6–59 months of age with moderate wasting
Association between asymptomatic infections and linear growth in 18–24‐month‐old Malawian children
Inadequate diet and frequent symptomatic infections are considered major causes of growth stunting in low-income countries, but interventions targeting these risk factors have achieved limited success. Asymptomatic infections can restrict growth, but little is known about their role in global stunting prevalence. We investigated factors related to length-for-age Z-score (LAZ) at 24 months by constructing an interconnected network of various infec…
The Provider Role and Perspective in the Denial of Family Planning Services to Women in Malawi
Family planning (FP) has been a global health priority for decades, yet barriers persist, including women being turned away from facilities without receiving services. This study assessed the provider role and perspective in client turnaway in three districts of Malawi. In 2019, data collectors surveyed 57 FP providers from 30 health facilities. All reported being comfortable providing FP to married women with children and married adolescents und…
Turned Away and at Risk
Family planning (FP) has been a development priority since the mid‐1990s, yet barriers to access persist globally, including women being turned away from facilities without a method. This study aimed to assess the extent of, and reasons for, FP turnaway in three districts of Malawi. In 2019, data collectors screened women exiting 30 health facilities and surveyed those who had been denied a method. Follow‐up surveys were conducted via telephone w…
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect…
Objectives: Inadequate iodine intake during pregnancy increases the risk of neonatal morbidity and mortality. We aimed to evaluate whether prenatal supplements containing iodine affect urinary iodine concentrations (UIC) of pregnant women in Malawi. Design: A randomised controlled trial. Pregnant women ( n 1391) were assigned to consume 60 mg/d Fe and 400 μg/d folic acid (IFA) or 18 vitamins and minerals including 250 μg/d iodine (MMN) or 20 g/d …
Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth
The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children
Objective Safety of home fortificants in children is uncertain in areas where infections are common. We tested the hypothesis that provision of lipid-based nutrient supplements (LNS) containing Fe does not increase infectious morbidity in children. Design Randomized controlled trial. Infants were randomised to receive 10, 20 or 40 g LNS/d; or no supplement until age 18 months. All LNS contained 6 mg Fe/d. Morbidity outcomes (serious adverse event…
Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth
Turned Away and at Risk
Family planning (FP) has been a development priority since the mid‐1990s, yet barriers to access persist globally, including women being turned away from facilities without a method. This study aimed to assess the extent of, and reasons for, FP turnaway in three districts of Malawi. In 2019, data collectors screened women exiting 30 health facilities and surveyed those who had been denied a method. Follow‐up surveys were conducted via telephone w…
The effect of providing lipid-based nutrient supplements on morbidity in rural Malawian infants and young children
Objective Safety of home fortificants in children is uncertain in areas where infections are common. We tested the hypothesis that provision of lipid-based nutrient supplements (LNS) containing Fe does not increase infectious morbidity in children. Design Randomized controlled trial. Infants were randomised to receive 10, 20 or 40 g LNS/d; or no supplement until age 18 months. All LNS contained 6 mg Fe/d. Morbidity outcomes (serious adverse event…
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect…
Objectives: Inadequate iodine intake during pregnancy increases the risk of neonatal morbidity and mortality. We aimed to evaluate whether prenatal supplements containing iodine affect urinary iodine concentrations (UIC) of pregnant women in Malawi. Design: A randomised controlled trial. Pregnant women ( n 1391) were assigned to consume 60 mg/d Fe and 400 μg/d folic acid (IFA) or 18 vitamins and minerals including 250 μg/d iodine (MMN) or 20 g/d …
Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth
Association between asymptomatic infections and linear growth in 18–24‐month‐old Malawian children
Inadequate diet and frequent symptomatic infections are considered major causes of growth stunting in low-income countries, but interventions targeting these risk factors have achieved limited success. Asymptomatic infections can restrict growth, but little is known about their role in global stunting prevalence. We investigated factors related to length-for-age Z-score (LAZ) at 24 months by constructing an interconnected network of various infec…
The Provider Role and Perspective in the Denial of Family Planning Services to Women in Malawi
Family planning (FP) has been a global health priority for decades, yet barriers persist, including women being turned away from facilities without receiving services. This study assessed the provider role and perspective in client turnaway in three districts of Malawi. In 2019, data collectors surveyed 57 FP providers from 30 health facilities. All reported being comfortable providing FP to married women with children and married adolescents und…
Turned Away and at Risk
Family planning (FP) has been a development priority since the mid‐1990s, yet barriers to access persist globally, including women being turned away from facilities without a method. This study aimed to assess the extent of, and reasons for, FP turnaway in three districts of Malawi. In 2019, data collectors screened women exiting 30 health facilities and surveyed those who had been denied a method. Follow‐up surveys were conducted via telephone w…
Developing the 2023 WHO guideline on wasting and nutritional oedema in infants and children
The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years has a broad scope aligned with WHO’s responsibility to develop a comprehensive guideline as part of the Global Action Plan on Child Wasting. A WHO technical team consisting of the WHO Steering Committee for this guideline, supported by a consultant and two independent methodologists, coordinated guid…
A WHO global research priority agenda for wasting and nutritional oedema in infants and children under 5 years
INTRODUCTION: The guideline development process for the WHO guideline on prevention and management of wasting and nutritional oedema highlighted extensive evidence gaps. We, the WHO Steering Committee and methodologists for the 2023 WHO guideline, therefore aimed to develop a comprehensive global research priority agenda for wasting and nutritional oedema in infants and children. It has a timeframe up to 2030 aligning with the Sustainable Develop…
Strengthening the evidence base around prevention and management of wasting and nutritional oedema in infants and children
box In 2023, WHO released a guideline on prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years as part of the Global Action Plan on Child Wasting, a consolidated framework to accelerate progress in prevention and management of wasting and nutritional oedema
Development of core outcome sets for effectiveness trials focused on infants and children with wasting and nutritional oedema
INTRODUCTION: The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema includes recommendations informed by best evidence from systematic reviews addressing critical and important outcomes. Multiple outcomes across trials were a challenge during guideline development, highlighting a need to establish core outcome sets (COS) for wasting and nutritional oedema. Informed by Core Outcome Measures in Effectiveness Tria…
Infants and children 6–59 months of age with moderate wasting
BOX The 2023 WHO guideline on wasting and nutritional oedema provides the first systematically developed evidence-informed set of recommendations and good practice statements for children 6–59 months of age with moderate wasting
Medicine (8 works) · Internal Medicine (6 works) · Child Nutrition and Water Access (5 works) · Wasting (5 works) · Guideline (4 works) · Pediatrics (4 works) · Child Nutrition and Feeding Issues (3 works) · Developing country (3 works) · Environmental health (3 works) · Global Maternal and Child Health (3 works)